Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T18:50:38.800Z.
Calculation as of: 2026-10-06T18:50:38.800Z.
Quote observation: 2026-10-06T18:49:55.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a5ea7848df566bb1fba137e14a23bd7a424b67da13a14cf2752e181034030ce3
PEG RATIO
N/A
HeartBeam, Inc.
Market Cap
$33.35M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| HeartBeam, Inc. (BEAT) | $33.35M | N/A |
| Scilex Holding Company (SCLX)vs › | $33.03M | N/A |
| Accuray Incorporated (ARAY)vs › | $33.46M | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.29M | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.42M | N/A |
| Elutia Inc (ELUT)vs › | $34.48M | N/A |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.19M | N/A |
| Rockwell Medical, Inc. (RMTI)vs › | $31.81M | N/A |
| DocGo Inc. (DCGO)vs › | $35.56M | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $35.71M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
